PsyPost on MSN

MDMA-assisted therapy shows promise for long-term depression relief

A recent study conducted in Norway suggests that MDMA-assisted therapy may provide lasting relief for individuals suffering from major depressive disorder. The findings indicate that the clinical ...
Task & Purpose

VA has $20 million for MDMA therapies, but that’s not all it needs

Congress approved $20 million for the U.S. Department of Veterans Affairs to begin MDMA-assisted therapies, but money isn’t all that’s needed to get the psychotherapy to veterans. Many veteran ...
NPR

Misconduct claims may derail MDMA psychedelic treatment for PTSD

People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA. MDMA is the chemical compound found in the drug commonly called ecstasy. In August, the Food and Drug ...
High Times

Dept. of Veteran Affairs To Fund Studies on Psilocybin and MDMA for PTSD, Depression

The Department of Veterans Affairs (VA) issued a request for applications (RFA) for proposals from its pool of researchers to study the vast potential of methylenedioxymethamphetamine (MDMA) and ...
The New York Times

F.D.A.’s Review of MDMA Cites Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. By ...
Fox News

FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time

A panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The meeting is the ...
Business Insider

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds

TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...
STAT

MDMA therapy is facing an imminent FDA decision. Here’s what you need to know

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...
Nasdaq

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

Research published in ACS Chemical Biology and BioDesign Research describes new approaches for producing tryptamine and MDMA-derived compounds The first paper, published in ACS Chemical Biology and ...
Star Tribune

Minnesota task force recommends decriminalizing ‘magic’ mushrooms

A Minnesota task force created to advise state lawmakers on policy issues surrounding psychedelic medicine released a report this week recommending the decriminalization of psilocybin-containing ...
The Scientist

Renewed faith in Ecstasy

Less than three years after the retraction of a controversial Science paper 1 on methyl-enedioxymethamphetamine (MDMA), the chemical used to make the illegal drug Ecstasy, two researchers in the ...